Kinnari Patel Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

Kinnari Patel is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 441,927 shares of RCKT, which is worth approximately $1.22 Million. The most recent transaction as insider was on May 20, 2025, when has been sold 767 shares (Common Stock) at a price of $6.45 per share, resulting in proceeds of $4,947. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 442K

0.49% 3M change

10.21% 12M change

Total Value Held $1.22 Million

Kinnari Patel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 20 2025	SELL Open market or private sale	$4,947 $6.45 p/Share	767 Reduced 0.17%	441,927 Common Stock
May 16 2025	SELL Open market or private sale	$9,200 $6.53 p/Share	1,409 Reduced 0.32%	442,694 Common Stock
Feb 21 2025	SELL Open market or private sale	$64,305 $10.58 p/Share	6,078 Reduced 1.35%	444,103 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	57,786 Added 11.38%	450,181 Common Stock
Nov 21 2024	SELL Open market or private sale	$59,873 $13.05 p/Share	4,588 Reduced 1.16%	392,395 Common Stock
Aug 16 2024	SELL Open market or private sale	$73,796 $18.5 p/Share	3,989 Reduced 0.99%	396,983 Common Stock
May 16 2024	SELL Open market or private sale	$94,474 $23.35 p/Share	4,046 Reduced 1.0%	400,972 Common Stock
May 14 2024	BUY Exercise of conversion of derivative security	-	9,543 Added 3.06%	301,824 Common Stock
Feb 16 2024	SELL Open market or private sale	$212,818 $29.84 p/Share	7,132 Reduced 2.91%	238,346 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	33,288 Added 10.92%	271,634 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	26,189 Added 9.64%	245,478 Common Stock
Nov 14 2023	BUY Exercise of conversion of derivative security	-	3,989 Added 1.78%	220,437 Common Stock
Aug 17 2023	SELL Open market or private sale	$23,730 $15.47 p/Share	1,534 Reduced 0.7%	216,448 Common Stock
Aug 14 2023	BUY Exercise of conversion of derivative security	-	3,989 Added 1.8%	217,982 Common Stock
May 17 2023	SELL Open market or private sale	$28,435 $21.38 p/Share	1,330 Reduced 0.62%	213,993 Common Stock
May 14 2023	BUY Exercise of conversion of derivative security	-	3,989 Added 1.82%	215,323 Common Stock
Feb 14 2023	BUY Other acquisition or disposition	-	38,735 Added 8.73%	405,018 Common Stock
Aug 12 2022	BUY Other acquisition or disposition	-	52,489 Added 12.53%	366,283 Common Stock
Feb 14 2022	BUY Other acquisition or disposition	-	11,970 Added 3.67%	313,794 Common Stock
Mar 24 2021	BUY Exercise of conversion of derivative security	$136,245 $1.45 p/Share	93,962 Added 33.21%	188,939 Common Stock
Dec 28 2020	SELL Open market or private sale	$952,695 $56.84 p/Share	16,761 Reduced 15.0%	94,977 Common Stock

Kinnari Patel

Cranbury, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Value

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT

Account